search

Agrylin

ANAGRELIDE HCL
*The product shipped may have different packaging depending on supplier/strength chosen

Agrylin

REQUIRED
ANAGRELIDE HCL
Select Strength
GENERIC
United Kingdom
Product Approved for Sale in the United Kingdom Manufactured by: Teva Pharma
BRAND
Canada
Product Approved for Sale in Canada Manufactured by: Shire Pharma
SWITCH & SAVE
Take advantage of our generic equivalent everyday low prices
SWITCH & SAVE
Take advantage of our generic equivalent everyday low prices

Select Quantity
Other Agrylin Options for Purchase:
Type
Product
Manufacturer
Country
Qty-price (USD)

Agrylin: Effective Platelet Reduction for Essential Thrombocythemia

Regulate High Platelet Levels to Prevent Clotting

Agrylin (anagrelide) is a prescription medication used to manage essential thrombocythemia, a condition characterized by high platelet counts in the blood. By reducing platelet production in the bone marrow, Agrylin helps lower the risk of serious complications such as blood clots, stroke, and heart attack.

Improve Blood Flow and Reduce Cardiovascular Risks

By preventing excessive platelet buildup, Agrylin enhances circulation and minimizes the risk of dangerous clot formation. This makes it a crucial treatment for individuals at risk of thrombosis, helping maintain healthy blood flow and overall vascular health.

Convenient Oral Capsule for Daily Use

Agrylin is available in an easy-to-take oral capsule, making it simple to incorporate into a daily routine. When taken as prescribed, it provides long-term platelet control and supports cardiovascular health, improving patient outcomes.